Synapse - Kylee Maclachlan

Results (155)

High WEE1 expression correlates with poor survival in multiple myeloma, independent of standard prognostic factors

Meeting Abstract

Simhal, A. K.; Firestone, R. S.; Oh, J. H.; Norton, L.; Hultcrantz, M.; Usmani, S. Z.; Maclachlan, K. H.; Deasy, J. O.
Blood (2024)

Fulltext@MSK | Save

Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma

Meeting Abstract

Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
Blood (2024)

Fulltext@MSK | Save

Manufacture of anti-BCMA CAR T cell is feasible after salvage autologous or allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Shah, G. L.; Perica, K.; Nagel, K.; Payson, E.; Hosszu, K. K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; more...
Blood (2024)

Fulltext@MSK | Save

Frailty and outcomes after bispecific T-cell engager therapy for patients with relapsed/refractory multiple myeloma

Meeting Abstract

Adegbite, B. O.; Tan, C. R.; Shekarkhand, T.; Firestone, R. S.; Jurgens, E. M.; Miller, K.; Lesokhin, A. M.; Shah, G. L.; Korde, N.; Rajeeve, S.; more...
Blood (2024)

Fulltext@MSK | Save

Defining the rates of cytokine release syndrome associated with Talquetamab step-up doses

Meeting Abstract

Hamadeh, I.; Shekarkhand, T.; Rueda, C.; Firestone, R.; Wang, A.; Korde, N.; Hultcrantz, M.; Lesokhin, A.; Mailankody, S.; Hassoun, H.; more...
Clinical Lymphoma, Myeloma and Leukemia (2024)

Fulltext@MSK | Save

Clonal evolution of multiple myeloma following the mutagenic impact of radiotherapy

Meeting Abstract

Diamond, B.; Chahar, D.; Jain, M.; Poos, A.; Durante, M.; Ziccheddu, B.; Maclachlan, K.; Davies, F.; Figura, N.; Morgan, G.; more...
Clinical Lymphoma, Myeloma and Leukemia (2024)

Fulltext@MSK | Save

Whole genome sequencing reveals lower APOBEC-mutational activity in multiple myeloma patients with African ancestry compared with those of non-African ancestry

Meeting Abstract

Maclachlan, K.; Papadimitriou, M.; Blaney, P.; McPherson, A.; Chu, T.; Diamond, B.; Ziccheddu, B.; Shekarkhand, T.; Poos, A.; Brown, E.; more...
Clinical Lymphoma, Myeloma and Leukemia (2024)

Fulltext@MSK | Save

Comprehensive genomic sequencing predicts sub-optimal response to bispecific antibodies (BsAb) and chimeric antigen receptor T cells (CAR-T) in multiple myeloma (MM)

Meeting Abstract

Maclachlan, K.; Shekarkhand, T.; Farzana, T.; Costa, B.; Firestone, R.; Jurgens, E.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Shah, U.; more...
Clinical Lymphoma, Myeloma and Leukemia (2024)

Fulltext@MSK | Save

Increased WEE1 expression is predictive of short progression-free survival, independent of standard prognostic factors in multiple myeloma

Meeting Abstract

Simhal, A.; Firestone, R.; Oh, J. H.; Norton, L.; Usmani, S.; Deasy, J.; Maclachlan, K.
Clinical Lymphoma, Myeloma and Leukemia (2024)

Fulltext@MSK | Save

Clinical outcomes of teclistamab among MajesTEC-1 eligible and ineligible population in the real-world setting for the treatment of relapsed/refractory multiple myeloma

Meeting Abstract

Tan, C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U.; Rajeeve, S.; Hashmi, H.; Shah, G.; more...
Clinical Lymphoma, Myeloma and Leukemia (2024)

Fulltext@MSK | Save